Evidence map›Paper›PMID 30200513›Full record

ArticleInternational journal of molecular sciences2018

Respiratory

Andreas Jeron, Julia D Boehme, Julia Volckmar, Marcus Gereke, Tetyana Yevsa, Robert Geffers, Carlos A Guzmán, Jens Schreiber, Sabine Stegemann-Koniszewski, Dunja Bruder

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. One year duration of immunity of a combinationFrontiers in veterinary science · 2025
    Article
  3. Clinical microbiology reviews · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Andreas JeronInfection Immunology Group, Institute of Medical Microbiology, Infection Control and Prevention, Health Campus Immunology, Infectiology and Inflammation, Otto-von-Guericke University Magdeburg, 39120 Magdeburg, Germany. Andreas.Jeron@med.ovgu.de.
Julia D BoehmeInfection Immunology Group, Institute of Medical Microbiology, Infection Control and Prevention, Health Campus Immunology, Infectiology and Inflammation, Otto-von-Guericke University Magdeburg, 39120 Magdeburg, Germany. Julia.Boehme@helmholtz-hzi.de.
Julia VolckmarInfection Immunology Group, Institute of Medical Microbiology, Infection Control and Prevention, Health Campus Immunology, Infectiology and Inflammation, Otto-von-Guericke University Magdeburg, 39120 Magdeburg, Germany. Julia.Volckmar@helmholtz-hzi.de.
Marcus GerekeInfection Immunology Group, Institute of Medical Microbiology, Infection Control and Prevention, Health Campus Immunology, Infectiology and Inflammation, Otto-von-Guericke University Magdeburg, 39120 Magdeburg, Germany. Marcus.Gereke@helmholtz-hzi.de.
Tetyana YevsaDepartment of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, 38124 Braunschweig, Germany. Tetyana.Yevsa@helmholtz-hzi.de.
Robert GeffersGenome Analytics Group, Helmholtz Centre for Infection Research, 38124 Braunschweig, Germany. Robert.Geffers@helmholtz-hzi.de.
Carlos A GuzmánDepartment of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, 38124 Braunschweig, Germany. CarlosAlberto.Guzman@helmholtz-hzi.de.
Jens SchreiberExperimental Pneumology, University Hospital for Pneumology, Health Campus Immunology, Infectiology and Inflammation, Otto-von-Guericke University Magdeburg, 39120 Magdeburg, Germany. Jens.Schreiber@med.ovgu.de.
Sabine Stegemann-KoniszewskiInfection Immunology Group, Institute of Medical Microbiology, Infection Control and Prevention, Health Campus Immunology, Infectiology and Inflammation, Otto-von-Guericke University Magdeburg, 39120 Magdeburg, Germany. Sabine.Stegemann-Koniszewski@med.ovgu.de.
Dunja BruderInfection Immunology Group, Institute of Medical Microbiology, Infection Control and Prevention, Health Campus Immunology, Infectiology and Inflammation, Otto-von-Guericke University Magdeburg, 39120 Magdeburg, Germany. Dunja.Bruder@med.ovgu.de.
Helmholtz Centre for Infection Research · DEOtto-von-Guericke University Magdeburg · DE

Funding

Deutsche Forschungsgemeinschaft IRTG1273Helmholtz-Gemeinschaft W2/W3-029
6 · The paper itself

Abstract

The respiratory tract is constantly exposed to the environment and displays a favorable niche for colonizing microorganisms. However, the effects of respiratory bacterial carriage on the immune system and its implications for secondary responses remain largely unclear. We have employed respiratory carriage with

Indexed as

VaccinationAdaptive ImmunityAnimalsAntibodies, BacterialBordetella bronchisepticaBordetella InfectionsCarrier StateCD5 AntigensCoinfectionInfluenza A virusListeria monocytogenesMiceMice, Inbred BALB CRespiratory Tract InfectionsT-Lymphocytes, RegulatoryAntibodies, BacterialCD5 AntigensCd5 protein, mouseBordetella bronchisepticainfluenza A virusListeria monocytogenespolymicrobial interactionsregulatory T cellsrespiratory immune regulationrespiratory microbial carriagesecondary infectionsvaccination

Identifiers

PMID30200513
PMCPMC6165163
OpenAlexW2889477034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.